Regen BioPharma Inc Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD from Q3 2017 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
Regen BioPharma Inc quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate from Q3 2017 to Q1 2024.
  • Regen BioPharma Inc Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending March 31, 2024 was -$5.18M, a 4.99% decline year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$5.18M -$246K -4.99% Mar 31, 2024 10-Q 2024-04-24
Q4 2023 -$5.24M -$357K -7.3% Dec 31, 2023 10-Q 2024-01-19
Q3 2023 -$5.1M +$2.93M +36.5% Sep 30, 2023 10-Q 2024-04-24
Q2 2023 -$5.03M +$3.32M +39.8% Jun 30, 2023 10-Q 2023-07-25
Q1 2023 -$4.93M +$71.8M +93.6% Mar 31, 2023 10-Q 2023-04-18
Q4 2022 -$4.88M +$4.87M +49.9% Dec 31, 2022 10-Q 2023-01-19
Q3 2022 -$8.04M +$5.45M +40.4% Sep 30, 2022 10-K 2023-11-20
Q2 2022 -$8.35M +$4.06M +32.7% Jun 30, 2022 10-Q 2022-07-22
Q1 2022 -$76.7M -$71.7M -1414% Mar 31, 2022 10-Q 2022-04-21
Q4 2021 -$9.76M -$4.17M -74.8% Dec 31, 2021 10-Q 2022-04-21
Q3 2021 -$13.5M -$6.15M -83.9% Sep 30, 2021 10-K 2022-11-15
Q2 2021 -$12.4M -$3.85M -45% Jun 30, 2021 10-K 2021-12-22
Q1 2021 -$5.07M +$6.7M +56.9% Mar 31, 2021 10-Q 2022-04-21
Q4 2020 -$5.58M +$2.12M +27.5% Dec 31, 2020 10-Q 2022-04-21
Q3 2020 -$7.33M +$3.57M +32.8% Sep 30, 2020 10-Q 2022-04-21
Q2 2020 -$8.56M +$4.23M +33.1% Jun 30, 2020 10-K 2021-12-22
Q1 2020 -$11.8M -$2.95M -33.5% Mar 31, 2020 10-K 2021-12-22
Q4 2019 -$7.7M +$957K +11.1% Dec 31, 2019 10-K 2021-12-22
Q3 2019 -$10.9M -$1.79M -19.6% Sep 30, 2019 10-K 2021-12-22
Q2 2019 -$12.8M -$4.22M -49.2% Jun 30, 2019 10-Q 2019-10-24
Q1 2019 -$8.81M -$268K -3.13% Mar 31, 2019 10-Q 2019-10-24
Q4 2018 -$8.66M -$857K -11% Dec 31, 2018 10-Q 2019-10-24
Q3 2018 -$9.12M -$3.87M -73.7% Sep 30, 2018 10-K 2021-06-21
Q2 2018 -$8.57M Jun 30, 2018 10-Q 2019-10-24
Q1 2018 -$8.55M Mar 31, 2018 10-Q 2019-10-24
Q4 2017 -$7.8M Dec 31, 2017 10-Q 2019-10-24
Q3 2017 -$5.25M Sep 30, 2017 10-Q 2019-10-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.